An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China
Clinical trial NCT05728502 · COMPLETED
Trial details
- NCT number
- NCT05728502
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-25
- Primary completion
- 2025-10-29
- Enrollment
- 2400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.